Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP422775.RALKhvl3gML8EXpinSZtbEpeMVlHmL6JeXlmVbghGh_nE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP422775.RALKhvl3gML8EXpinSZtbEpeMVlHmL6JeXlmVbghGh_nE130_assertion type Assertion NP422775.RALKhvl3gML8EXpinSZtbEpeMVlHmL6JeXlmVbghGh_nE130_head.
- NP422775.RALKhvl3gML8EXpinSZtbEpeMVlHmL6JeXlmVbghGh_nE130_assertion description "[Our data suggested that epigenetic silencing of SFRP5 leads to oncogenic activation of the Wnt pathway and contributes to ovarian cancer progression and chemoresistance through the TWIST-mediated EMT and AKT2 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP422775.RALKhvl3gML8EXpinSZtbEpeMVlHmL6JeXlmVbghGh_nE130_provenance.
- NP422775.RALKhvl3gML8EXpinSZtbEpeMVlHmL6JeXlmVbghGh_nE130_assertion evidence source_evidence_literature NP422775.RALKhvl3gML8EXpinSZtbEpeMVlHmL6JeXlmVbghGh_nE130_provenance.
- NP422775.RALKhvl3gML8EXpinSZtbEpeMVlHmL6JeXlmVbghGh_nE130_assertion SIO_000772 19957335 NP422775.RALKhvl3gML8EXpinSZtbEpeMVlHmL6JeXlmVbghGh_nE130_provenance.
- NP422775.RALKhvl3gML8EXpinSZtbEpeMVlHmL6JeXlmVbghGh_nE130_assertion wasDerivedFrom befree-20140225 NP422775.RALKhvl3gML8EXpinSZtbEpeMVlHmL6JeXlmVbghGh_nE130_provenance.
- NP422775.RALKhvl3gML8EXpinSZtbEpeMVlHmL6JeXlmVbghGh_nE130_assertion wasGeneratedBy ECO_0000203 NP422775.RALKhvl3gML8EXpinSZtbEpeMVlHmL6JeXlmVbghGh_nE130_provenance.